A A

Archive | April, 2011

FOCUS Immunology Laboratory Heidelberg (GLP-certified)

Tuesday, April 19, 2011

0 Comments

Fully equipped tissue culture facility, flow cytometry,
multiformat reader, PCR

Cytokine Release Assays for Safety Assessment of Biologicals

Immunogenicity testing

Functional testing of immune cells for mode-of-action analysis

Immune-monitoring of clinical trials

PK/PD assessment for Biologicals/Biosimilars


Cytokine Release Assays for Safety Assessment of Biologicals

  • Combination of cell culture, stimulation and cytokine detection
  • Stimulation of whole blood or defined cellular subpopulations
  • Protocols consider post TGN 1412 requirements

Immunogenicity Testing According to EMA Guidelines

  • Assay development, validation and GLP-compliant performance
  • Screening assays
  • Confirmatory assays
  • Assays for neutralizing antibodies
  • Various ELISA formats available: Bridging, direct, competitive
  • Cellular immunity assessment

Cell-based Functional Assays

Proliferation

  • Metabolic (ATP) assay via luminescence
  • CFSE and BrdU assay via fluorescence

Intracellular Cytokine Staining (ICS)

  • Multi-parametric analysis for detection of multiple cytokine producing cells

Apoptosis

  • Caspase 3/7 induction
  • Annexin V assay
  • Cell Morphology

Cytotoxicity

  • LDH release
  • Protease release

NO-production

Histamine release

Innate immunity evaluation via stimulation of
Toll-like receptors (“TLR stimulation assays”)


Lymphocyte Stimulation Assays
Defined healthy blood donors under EC vote

Immune Cell Preparations

  • Whole blood
  • Peripheral Blood Mononuclear Cells (PBMC)
  • Purified subpopulations

Antigen specific stimulations

  • CMV-peptides
  • PPD
  • Tetanus Toxoid
  • Influenza Peptides

Polyclonal stimulations

  • Antibody-mediated, e. g. antiCD3/CD28
  • Mitogens, e. g. PHA and LPS
  • PMA and Ionomycin
  • “Superantigens” e. g. SEB

Functional read-out after stimulation

  • Proliferation
  • Cytokine Release (ELISA, ELISPOT, ICS)
  • Induction of apoptosis
  • Cytotoxicity

Fully Equipped

  • Tissue Culture
  • Flow cytometry
  • Mulitformat Reader
  • PCR

Mediator/Cytokine Analysis “ready to go”:


Contact

Dr. Eddy Bruyns
Phone: +49 6221 64935-124
Fax: +49 6221 64935-110
eddy.bruyns@focus-cdd.com

FOCUS CDD GmbH
Im Neuenheimer Feld 515
69120 Heidelberg

Dr. Karl Michaelis
Phone: +49 731 9840-240
Fax: +49 7319840-324
karl.michaelis@nuvisan.de

Nuvisan GmbH
Wegenerstrasse 13
89231 Neu-Ulm

www.focus-immunology.com

Full Service CRO
driven by Experience, Commitment, Technology

www.nuvisan.com

All Services under one roof

LAB Services

  • Bioanalytics
  • Pharmaceutical Analytics
  • Clinical Trial Supplies
  • Biopharmaceuticals

Focus Phase I

  • Early Stage Clinical Development
  • FIM/FIP/BE Studies
  • Ethnicity Bridging Studies

Phase II – IV

  • Oncology
  • EDC Solutions
  • Biostatistics
  • Regulatory Affairs